Related by context. All words. (Click for frequent words.) 78 Hb A1C 78 HbA 1c levels 77 HbA 1c 76 hemoglobin A1c levels 75 HbA1c levels 75 A1c levels 75 hemoglobin A1c HbA1c 74 albumin excretion 74 baseline HbA1c 74 glycated hemoglobin levels 73 PASI scores 73 HOMA IR 73 HbA1C 73 nondiabetic patients 72 serum phosphate levels 72 mmHg diastolic 72 Hb A1c 72 #.#mmol L [002] 71 mL/min/#.# m 2 71 CVD mortality 71 nonfasting triglyceride levels 71 postoperative mortality 71 tertiles 71 hemoglobin A1C 71 serum urate 71 lumbar spine BMD 71 albumin excretion rate 70 triacylglycerol concentrations 70 baseline A1C 70 hip BMD 70 glycosylated hemoglobin levels 70 Fasting plasma glucose 70 Triglyceride levels 70 CHD mortality 70 glycosylated hemoglobin HbA1c 70 MMSE score 70 serum creatinine levels 70 peak VO2 70 lowest tertile 70 serum uric acid 70 serum triglycerides 69 glycated hemoglobin 69 serum urate levels 69 serum lipid levels 69 neutrophil counts 69 oxycodone CR 69 NPH insulin 69 glycated hemoglobin HbA1c 69 metabolic parameters 69 urine albumin 69 #.#/#.# mmHg [001] 69 attain statistical significance 69 diastolic BP 69 hemoglobin concentrations 69 MMSE scores 69 systolic BP 69 NNT = 69 pCR 69 pulmonary capillary wedge 69 fasting glucose levels 69 tertile 68 fasting triglyceride levels 68 creatinine ratio 68 serum PTH 68 serum concentrations 68 highest tertile 68 nonobese 68 systolic blood pressures 68 mmol l 68 Calcium intake 68 mm Hg systolic 68 plasma triglycerides 68 CI -#.# 68 severe hypoglycaemia 68 glycosylated hemoglobin 68 Baseline characteristics 68 BMI z 68 binary restenosis 68 confidence intervals CIs 68 % CI #.#-#.# [008] 68 #mmHg [001] 68 #mmHg [002] 68 MADRS score 68 diastolic pressures 68 poor metabolizers 67 -#.# mg dL [002] 67 triglyceride concentrations 67 nonvertebral fracture 67 leukocyte count 67 abdominal circumference 67 elevated LDL cholesterol 67 Score DAS# 67 intima media thickness 67 femoral neck BMD 67 Diastolic pressure 67 A1C levels 67 serum homocysteine 67 Operative mortality 67 arterial oxygen saturation 67 arterial thromboembolic events 67 rimonabant #mg 67 glycaemia 67 polyp recurrence 67 fasting plasma glucose FPG 67 hydroxyvitamin D levels 67 ejection fractions 67 elevated triglyceride levels 67 EDSS score 67 mm Hg diastolic 67 mmHg systolic 67 Fasting glucose 67 CI #.#-#.# [002] 67 intact parathyroid hormone 67 serum IGF 67 atheroma volume 67 HbA 1C 67 Complication rates 67 colorectal adenoma 67 serum phosphate 67 #.#mmHg 67 HER2 expression 67 adiponectin concentrations 67 triglyceride concentration 67 systolic dysfunction 67 homocysteine concentrations 67 PSA nadir 66 severe exacerbations 66 CLA supplementation 66 diastolic blood pressures 66 definite stent thrombosis 66 mIU ml 66 CrCl 66 hypoglycemic events 66 nocturnal hypoglycaemia 66 ALT elevation 66 serum triglyceride levels 66 EDSS scores 66 multivariable adjusted 66 fasting insulin 66 endometrial thickness 66 perioperative mortality 66 hsCRP levels 66 sUA levels 66 LV dysfunction 66 confidence interval #.#-#.# 66 μg dL 66 CPAP adherence 66 #OHD levels 66 nmol l 66 transaminase levels 66 apolipoprotein B 66 glomerular filtration 66 advanced adenoma 66 arterial stiffening 66 hydroxyvitamin D concentrations 66 NYHA functional class 66 HbA1c 66 #OHD 66 mmol liter 66 neurodevelopmental impairment 66 serum calcium levels 66 plasma homocysteine 66 serum CRP 66 noncardiovascular mortality 66 atherogenic dyslipidemia 66 serum aminotransferase levels 66 #.#mmol l [002] 66 postintervention 66 Ishak fibrosis score 66 Insulin sensitivity 66 baseline serum creatinine 66 HBeAg seroconversion 66 mean baseline A1C 66 elevated hsCRP 66 plasma glucose levels 66 serum magnesium 66 morphometric vertebral fractures 66 thyrotropin levels 66 preoperative PSA 66 tapentadol ER 66 highest quintile 66 QTcF 66 improves glycemic 66 echocardiographic parameters 66 elevated ALT 65 Fasting blood glucose 65 fasting triglycerides 65 p = .# [002] 65 visceral adiposity 65 -#.# mg dL [001] 65 corticosteroid dose 65 CI #.#-#.# [001] 65 recurrent VTE 65 serum lipid 65 adenoma recurrence 65 ADCS ADL 65 elevated fasting glucose 65 postoperative complication 65 serum parathyroid hormone 65 #mg/day [001] 65 serum vitamin D 65 elevated LDH 65 glycemia 65 tHcy concentrations 65 lipid profiles 65 % Confidence Interval 65 mean baseline HbA1c 65 carotid IMT 65 sUA 65 statistical significance p 65 statin monotherapy 65 magnesium intake 65 #/#mmHg 65 umol L 65 serum potassium 65 nondiabetic 65 detemir 65 preintervention 65 symptomatic intracranial hemorrhage 65 SGRQ 65 serum sodium levels 65 folate concentrations 65 TEAEs 65 alanine aminotransferase 65 nonsignificant difference 65 achieved ACR# 65 atorvastatin #mg 65 Breslow thickness 65 timepoints 65 dietary calcium intake 65 #.#mmol L [001] 65 inflammatory biomarkers 65 DLQI 65 macrovascular events 65 thiazide diuretics 65 odds ratios ORs 65 #mg/dL [001] 65 % CI #.#-#.# [003] 65 baseline LDH 65 serum PSA 65 recurrent venous thromboembolism 65 symptomatic intracerebral hemorrhage 65 CDAI score 65 Homocysteine levels 65 plasma homocysteine levels 65 blood glucose concentrations 64 extrapyramidal symptoms 64 comorbid illnesses 64 OGTT 64 elevated IOP 64 QALE 64 lipid lowering medications 64 isoflavone intake 64 liver histology 64 serum phosphorus 64 Viral load 64 Serum creatinine 64 certolizumab 64 PSADT 64 lipid lowering agents 64 alanine aminotransferase ALT 64 dose Iluvien 64 thyroid hormone levels 64 μmol L 64 urinary albumin excretion 64 Subgroup analyzes 64 CR nPR 64 NHANES III 64 biphasic insulin aspart 64 lipid levels 64 P = .# 64 glomerular filtration rate 64 advanced adenomas 64 hemoglobin Hb 64 #.#mg/dL 64 serum LDL cholesterol 64 postprandial insulin 64 HDL cholesterol triglycerides 64 relapsed MM 64 hypertensives 64 μg L 64 postoperative morbidity 64 Hemoglobin A1c 64 carotid artery intima media 64 exhaled NO 64 N telopeptide 64 tipranavir r 64 hemoglobin A1c 64 acromegalic patients 64 β blockers 64 biochemical recurrence 64 plasma folate 64 isolated systolic hypertension 64 Charlson comorbidity index 64 antidiabetic medications 64 LDL triglycerides 64 complete cytogenetic response 64 venlafaxine XR 64 nondepressed 64 LS BMD 64 plasma leptin 64 sociodemographic factors 64 undetectable viral 64 macroalbuminuria 64 Preterm infants 64 TT genotype 64 PRADAXA #mg 64 g dl 64 nonfasting triglycerides 64 Crohn Disease Activity 64 FDA defined valvulopathy 64 anemia hemoglobin 64 tHcy 64 Univariate analysis 64 VO2 peak 64 elevated LDL 64 SUVmax 64 fructosamine 64 BMI percentiles 64 p = .# [001] 64 cerebrovascular events 64 waist girth 64 fasting plasma glucose 64 serum calcium 64 6MWD 64 μg liter 64 PUFA intake 64 BENICAR HCT 64 nonfatal MI 64 Calorie intake 64 urinary albumin 64 prepregnancy BMI 64 adjunctive placebo 63 parous women 63 hemoglobin concentration 63 RBP4 levels 63 systolic diastolic 63 aminotransferases 63 mmHg p = 63 serum folate 63 MetS 63 postprandial blood glucose 63 CK # plasma concentrations 63 p = #.# [003] 63 colorectal cancer incidence 63 mEq L 63 octreotide LAR 63 nonvertebral fractures 63 angiographic restenosis 63 Secondary efficacy endpoints 63 % CI #.#-#.# [007] 63 Hazard Ratio = 63 severe periodontitis 63 Hazard Ratio HR 63 NIHSS score 63 carotid stenosis 63 oral hypoglycemic agent 63 colorectal neoplasia 63 T2 lesions 63 salivary flow 63 hypoglycemic episodes 63 troponin T 63 mg BID dose 63 arterial thickening 63 fasting glucose 63 achieved statistical significance 63 nmol L. 63 treat NNT 63 serum testosterone 63 normal ULN 63 inhospital 63 cerebral oxygenation 63 -#.# log# 63 postprandial glucose 63 blood Phe levels 63 salmeterol fluticasone 63 % CI #.#-#.# [004] 63 plasma glucose concentration 63 antidiabetic medication 63 Febrile neutropenia 63 serum ferritin 63 lipid parameters 63 HAQ DI 63 hypertension diabetes mellitus 63 moderate renal impairment 63 symptomatic VTE 63 adiponectin levels 63 normotensive 63 gm dl 63 multivariate adjustment 63 estimated glomerular filtration 63 mIU L 63 #mg/day [002] 63 mineral density 63 creatinine levels 63 serum estradiol 63 nondiabetics 63 posttreatment 63 #.#ng/ml 63 nmol L 63 inhospital mortality 63 -#.# ± [002] 63 mL/min/#.# m2 63 multivariable analysis 63 adjunctive ABILIFY 63 HIV HCV coinfected 63 oral antidiabetes 63 Cmax 63 prolactin levels 63 oral antidiabetic medication 63 abdominal adiposity 63 nonsignificant 63 urinary cadmium 63 LDL HDL 63 SHBG levels 63 antibody titer 63 univariate analyzes 63 serum phosphorus levels 63 hepatorenal syndrome 63 hours postdose 63 PCWP 63 myocardial infarctions MIs 63 ADCS CGIC 63 glycemic variability 63 lispro 63 dyslipidaemia 63 waist circumferences 63 lymphocyte count 63 titrated glipizide plus 63 CHD CVD 63 SGPT 63 mean serum phosphorus 62 Platelet counts 62 bioavailable testosterone 62 titrated glipizide 62 serum glucose 62 nadroparin 62 P ≤ 62 serum retinol 62 unresectable HCC 62 insulin detemir 62 p = NS 62 diastolic hypertension 62 aspartate aminotransferase AST 62 paricalcitol 62 gestational diabetes mellitus GDM 62 fasting serum 62 #mg/dL [002] 62 aminotransferase levels 62 kg m² 62 metformin monotherapy 62 oral prednisolone 62 low dose Iluvien 62 estimated GFR 62 left ventricular diastolic 62 pretreatment baseline 62 Endothelial function 62 protein excretion 62 PASI score 62 NIHSS 62 perioperative complications 62 androgen depletion 62 overt nephropathy 62 tumor histology 62 psychiatric comorbidities 62 recurrent tonsillitis 62 beta blocker therapy 62 annualized relapse 62 1mg dose 62 comorbid conditions 62 dose statin therapy 62 receiving ISENTRESS 62 oxygen desaturation 62 systolic blood pressure 62 postprandial glycemia 62 #mm Hg 62 eosinophil count 62 sustained virological response 62 apnea hypopnea index 62 LDL HDL ratio 62 iPTH 62 A1Cs 62 μg d 62 prepregnancy 62 Stent thrombosis 62 NATRECOR R 62 calculated creatinine clearance 62 neurodevelopmental outcomes 62 basal bolus therapy 62 periprocedural MI 62 HDL LDL ratio 62 DAS# remission 62 SCr 62 creatinine clearance 62 Postoperatively 62 KRAS mutations occur 62 UPDRS scores 62 prevalences 62 polytherapy 62 abnormal lipid levels 62 bezafibrate 62 PDP MLR 62 cardio respiratory fitness 62 serum testosterone levels 62 serum clusterin levels 62 μg kg 62 cholesterol triglyceride 62 Apgar scores 62 serologically active patients 62 HRQL 62 WOMAC pain 62 T2 lesion volume 62 urate levels 62 incontinence episodes 62 hypoglycaemic episodes 62 mg simvastatin 62 experienced virologic failure 62 serum cholesterol 62 specific antigen PSA 62 prospectively defined 62 IR Cysteamine 62 lifetime abstainers 62 apo B 62 acarbose 62 serum phosphorous 62 obstructive CAD 62 serum bicarbonate 62 acetaminophen codeine 62 NNRTI resistance 62 abdominal girth 62 fragility fracture 62 impaired glucose metabolism 62 peak plasma concentrations 62 pg ml 62 Heavy menstrual bleeding 62 achieving PASI 62 elevated uric acid 62 = #.#-#.# 62 ICD therapy 62 angiographic outcomes 62 LDL cholesterol concentrations 62 ghrelin concentrations 62 linoleic acid LA 62 severe hypoglycemic episodes 62 waist circumference measurements 62 tirofiban 62 serum cortisol 62 sociodemographic characteristics 62 mTSS 62 IOP lowering 62 nicardipine 62 platelet reactivity 62 BRCA1 mutation carriers 62 hyperglycaemia 61 leukocyte counts 61 suboptimal adherence 61 urinary excretion 61 diastolic pressure 61 serum potassium levels 61 hyperlipidaemia 61 serum lipids 61 nonfasting 61 % CI #.#-#.# [006] 61 HBeAg negative patients 61 depressive symptomatology 61 baseline FEV 61 death reinfarction 61 ratio ICER 61 per deciliter mg 61 #mg dose [002] 61 medication nonadherence 61 spirometric 61 clinically meaningful reductions 61 x ULN 61 plasma glucose 61 noncardiac 61 triglyceride TG 61 aged ≥ 61 anthropometric measures 61 nocturnal hypoglycemia 61 onset diabetes mellitus 61 serum albumin 61 plasma lipids 61 atherogenic lipids 61 EDARBI 61 stent binary restenosis 61 CORE OM 61 β = 61 foveal thickness 61 serum HBV DNA 61 Index CDAI 61 -#.# ± [001] 61 subclinical atherosclerosis 61 ARB telmisartan 61 hepatic insulin sensitivity 61 HAM D# scores 61 tolterodine ER 61 ADAS cog 61 serum folate concentrations 61 dapagliflozin plus 61 dose atorvastatin 61 dose clopidogrel 61 asymptomatic carotid stenosis 61 progression TTP 61 confidence interval CI 61 ELBW infants 61 serum BDNF 61 IV bisphosphonates 61 cardiac autonomic 61 #mg/dl 61 urinary oxalate 61 generalized edema 61 pravastatin therapy 61 subclinical hyperthyroidism 61 GI toxicity 61 prednisone prednisolone plus 61 symptom exacerbation 61 antioxidant supplementation 61 elevated creatinine 61 Lipitor #mg 61 autonomic dysfunction 61 maximal doses 61 metabolite concentrations 61 postdischarge 61 femoral neck fracture 61 UPDRS motor 61 CIN3 61 PaO 2 61 APTIVUS r 61 carotid intima media 61 REYATAZ r arm 61 postoperative AF 61 Lumbar spine 61 beta carotene supplementation 61 clodronate 61 microvascular complications 61 CCyR 61 glucose concentrations 61 histologic subtype 61 density lipoprotein cholesterol 61 periprocedural 61 symptomatic hypotension 61 cholesterol LDL C 61 cardiovascular mortality 61 serum triglyceride 61 QALYs 61 T2DM 61 AST ALT 61 serum leptin 61 Caloric intake 61 obstructive coronary artery 61 pT3 61 Primary endpoints 61 del 5q MDS 61 distal colon cancer 61 coronary stenosis 61 shorter telomere length 61 coronary revascularization procedures 61 abnormal lipid 61 interindividual variability 61 UACR 61 segment binary restenosis 61 IDDM 61 intravenous diuretics 61 XEPLION R 61 pulmonary dysfunction 61 -#.# log# copies mL 61 lopinavir r arm 61 osteopenic 61 vertebral fracture 61 antihypertensive medication 61 atazanavir ritonavir 61 urinary protein 61 ALT AST 61 systolic diastolic blood 61 apnea hypopnea 61 DHEA supplementation 61 receiving Vectibix monotherapy 61 tapentadol IR 61 patients undergoing CABG 61 flow mediated dilation 61 baseline CD4 61 Cardiorespiratory fitness 61 carb dieters 61 serum selenium 61 hematologic toxicity 61 antihypertensive medications 61 deep venous thromboses 61 methotrexate monotherapy 61 advanced neoplasia 61 perioperative morbidity 61 cardiorespiratory fitness 61 euthyroid 61 serum insulin 61 plasma renin 61 postprocedure 61 potential confounders 61 + PH# 61 PANSS scores 61 serum sodium 61 hepatic enzymes 61 hemoglobin A1C HbA1C 61 locoregional recurrence 61 sodium excretion 61 ml kg 61 mU L 61 posttransplant 61 salivary cortisol 61 hematopoietic cancers 61 neurodevelopmental outcome 61 kcal d 61 leucopenia 61 FeNO 61 oral antidiabetic drugs 61 serum GGT 61 log# copies mL 61 hypercholesterolaemia 61 Adverse effects 61 MELD scores 61 PREZISTA r arm 61 ALT flares 61 CLBP 61 allele frequencies 60 latent celiac disease 60 fasting blood glucose 60 nocturnal awakenings 60 recurrent UTI 60 #ng/ml 60 pmol L 60 lymphocytosis 60 distensibility 60 ng dL 60 Ejection Fraction 60 CC genotype 60 systolic function 60 linaclotide treated 60 isoprostane 60 salpingo oophorectomy 60 dizziness nausea diarrhea 60 haemorrhagic stroke 60 statistically significant p = 60 NIH CPSI 60 #.#/#.# mm Hg [003] 60 serum ALT 60 glargine 60 mg hydrochlorothiazide 60 dosing frequency 60 pulmonary exacerbations 60 lowering systolic blood 60 fasting plasma 60 DAS# CRP 60 aldosterone antagonist 60 nmol liter 60 fraction LVEF 60 reinfarction 60 dietary folate 60 prospectively stratified 60 choline intake 60 Secondary endpoints included 60 Secondary endpoints include 60 transaminase elevations 60 ACR# responses 60 fenofibrates 60 urinary N telopeptide 60 lipid lowering therapy 60 Pharmacokinetic parameters 60 urodynamic parameters 60 blood lipid profiles 60 dalteparin 60 T1DM 60 multivariable analyzes 60 conjugated equine estrogen 60 obese adolescents 60 psychosocial variables 60 androgen suppression 60 #-#,# mg 60 nonpregnant women 60 Moderate drinkers 60 8 OHdG 60 sd = 60 glimepiride 60 abnormal glucose tolerance 60 leptin concentrations 60 BRCA2 mutation carriers 60 retinal thickness 60 interobserver reliability 60 symptomatic GERD 60 #.#/#.# mm Hg [001] 60 XIENCE V demonstrated 60 laboratory abnormalities 60 Visual Analogue Scale VAS 60 dietary folate intake 60 spontaneous preterm delivery 60 loop diuretics 60 4mg/kg 60 oxycodone IR 60 mg XP# 60 systemic embolism 60 Avandia Actos 60 milligrams deciliter 60 nighttime awakenings 60 tic severity 60 sperm morphology 60 serum TSH 60 postdose 60 fractional anisotropy 60 VLBW 60 Symptom severity 60 oocytes retrieved 60 AUA Symptom Score 60 vaginal hysterectomy 60 hemorrhagic complications 60 hormone receptor negative 60 PLX STROKE targeting 60 RYGB 60 perioperatively 60 LVEF 60 ATACAND 60 clinically meaningful improvement 60 hsCRP 60 dysglycemia 60 Drug eluting stent 60 Serum calcium 60 azilsartan medoxomil 60 cTnT levels 60 hemodynamic parameters 60 microg 60 gastrointestinal bleeds 60 LV ejection fraction 60 intracranial hemorrhage ICH 60 IRLS score 60 primary aldosteronism 60 timepoint 60 hypogonadal men 60 Fasting glucose levels 60 intraobserver 60 angiotensin II receptor blockers 60 artery stenosis 60 interquartile range 60 postop 60 Subgroup analysis 60 subclinical hypothyroidism 60 biochemical relapse 60 thyrotropin 60 macrovascular disease 60 Logistic regression analysis 60 pg mL 60 d dimer 60 gastric pH 60 microalbuminuria 60 hippocampal volumes 60 impaired endothelial 60 spine BMD 60 AUCs 60 PANSS total 60 elevated serum creatinine 60 coronary calcification 60 TURBT 60 baseline FEV1 60 undergone bariatric surgery 60 arterial stiffness 60 APOE genotype 60 mild renal insufficiency 60 carotid bruit 60 lipoprotein Lp 60 biopsy Gleason 60 placebo dexamethasone 60 IPAH 60 AUA BPH Symptom Score 60 Viread Emtriva Sustiva 60 univariate analysis 60 psychiatric comorbidity 60 mineral density BMD 60 undergoing bariatric surgery 60 prednisone prednisolone 60 elevated triglycerides 60 sulfonylurea metformin 60 lumbar spine bone 60 Apidra ® 60 neurocognitive function 60 comparator arm 60 mL sec 60 seroprotection 60 rebleeding 60 anastomotic leak 60 FTO variant 60 conditional logistic regression 60 neurocognitive functioning 60 glulisine 60 diameter stenosis 60 Index CDAI score 60 ventricular enlargement 60 CYP#D# inhibitor 60 INRs 60 LDB CPR 60 Intraocular pressure 60 FOSRENOL ® 60 urinary calcium 60 hematological parameters 60 residual platelet reactivity 60 prolonged QT interval 60 vaginal progesterone gel 60 ejection fraction EF 60 transferrin saturation 60 microbiologically evaluable 60 CIMZIA ™ 60 Systolic blood pressure 60 undetectable HBV DNA 60 sitosterol 60 hemodialysis patients 60 TC HDL 60 Cystatin C 60 MACCE 60 plus MTX 60 sweat chloride 60 hip resurfacing arthroplasty 60 LAGB 60 HIV uninfected 60 virological suppression 60 gallstone disease 60 sleeve lobectomy 60 genotypic resistance 60 plasma HCV RNA 60 flavonoid intake 60 hippocampal volume 60 nonfatal myocardial infarction MI 60 pmol liter 59 Carbohydrate intake 59 methacholine challenge 59 receiving antiretroviral therapy 59 IBDQ 59 graft occlusion 59 IFN alfa 59 preoperative chemotherapy 59 visceral abdominal 59 systemic corticosteroid 59 lactate dehydrogenase 59 mU liter 59 neurologic outcomes 59 severe renal impairment 59 total cholesterol triglycerides 59 mcg BID 59 Lucentis monotherapy 59 endometrial hyperplasia 59 ACR# ACR# 59 inhaled glucocorticoids 59 XIENCE V PROMUS Stent 59 Postoperative complications 59 placebo fluoxetine 59 carotid plaque 59 mRS 59 Low birthweight 59 viral titers 59 cerebral infarction 59 cardiovascular hospitalizations 59 malabsorptive 59 paraprotein 59 ginkgo biloba extract 59 dosing cohort 59 glipizide plus 59 plasma cortisol 59 dietary glycemic index 59 underwent bariatric surgery 59 LDL cholesterol levels 59 metabolic dysregulation 59 mesalamine granules 59 prolactin elevation 59 subcutaneous insulin 59 diabetic hypertensive 59 albuminuria 59 clinically meaningful improvements 59 Erythropoietic therapies may 59 venous thromboembolic disease 59 dietary carbohydrate 59 logistic regression model 59 bilateral oophorectomy 59 mcg dL 59 dietary sodium 59 affective psychosis 59 serum bilirubin 59 adenoma detection 59 dietary fiber intake 59 serum IgE 59 recurrent ischemia 59 DAS# [002] 59 dietary sodium intake 59 colorectal polyp 59 receiving VICTRELIS 59 TAXUS p value 59 Fibromyalgia Impact Questionnaire 59 hyperhomocysteinemia 59 depressive symptom 59 analgesic medications 59 revascularizations 59 otamixaban 59 benazepril 59 symptomatic carotid stenosis 59 plus methotrexate 59 postoperative chemotherapy